Seres Therapeutics (MCRB) Current Leases (2019 - 2026)
Seres Therapeutics (MCRB) posted Current Leases of $10.9 million for Q1 2026, up 4.57% sequentially from $10.4 million in Q4 2025, and up 20.07% YoY from $9.0 million in Q1 2025.
Seres Therapeutics (MCRB) Current Leases (2019 - 2026) Analysis & Trends
Seres Therapeutics has reported Current Leases for 8 years, with the latest figure at $10.9 million in Q1 2026.
- Quarterly Current Leases rose 20.07% year-over-year to $10.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.9 million (up 20.07% YoY) and the FY2025 annual result came in at $10.4 million, up 19.78% from the prior year.
- Current Leases rose to $10.9 million in Q1 2026 per MCRB's latest filing, from $10.4 million in the prior quarter.
- Over five years, Current Leases peaked at $10.9 million in Q1 2026 and troughed at $3.6 million in Q4 2022.
- A 5-year average of $7.7 million and a median of $8.3 million in 2024 frame the typical range for Current Leases.
- The sharpest annual moves came in 2022 and 2024: Current Leases sank 45.52% in 2022, then surged 84.64% in 2024.
- Over 5 years, Current Leases stood at $3.6 million in 2022, then soared by 55.15% to $5.6 million in 2023, then soared by 55.25% to $8.7 million in 2024, then advanced by 19.78% to $10.4 million in 2025, then rose by 4.57% to $10.9 million in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $10.9 million, $10.4 million, and $9.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.82 Bn | 131.97 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.70 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 65.23 Bn | 60.05 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.16 Bn | 55.02 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.86 Bn | 28.55 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.24 Bn | 9.85 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | - |
| 10 | Seres Therapeutics | 44.50 Mn | 44.50 Mn | - | 11.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.83 Mn |
| Mar 31, 2026 | 10.87 Mn |
| Dec 31, 2025 | 10.39 Mn |
| Sep 30, 2025 | 9.92 Mn |
| Jun 30, 2025 | 9.48 Mn |
| Mar 31, 2025 | 9.05 Mn |
| Dec 31, 2024 | 8.67 Mn |
| Sep 30, 2024 | 8.35 Mn |
| Jun 30, 2024 | 9.20 Mn |
| Mar 31, 2024 | 8.83 Mn |
| Dec 31, 2023 | 5.59 Mn |
| Sep 30, 2023 | 6.28 Mn |
| Jun 30, 2023 | 5.47 Mn |
| Mar 31, 2023 | 4.78 Mn |
| Dec 31, 2022 | 3.60 Mn |
| Sep 30, 2022 | 7.33 Mn |
| Jun 30, 2022 | 7.06 Mn |
| Mar 31, 2022 | 6.85 Mn |
| Dec 31, 2021 | 6.61 Mn |
| Sep 30, 2021 | 6.10 Mn |